✦ LIBER ✦

Abnormalities of quantitative dinitrochlorobenzene sensitization in cancer patients: Correlation with tumor stage and histology

✍ Scribed by William J. Catalona; Paul B. Chretien

Publisher: John Wiley and Sons
Year: 1973
Tongue: English
Weight: 326 KB
Volume: 31
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197302)31:2<353::aid-cncr2820310213>3.0.co;2-b

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunologic impairment in patients with

Immunologic impairment in patients with non-lymphoid cancer. Correlation with the tumoral stage, response to treatment, and survival

✍ E. Simó-Camps; A. Anguera; J. Ma Vich; A. Vidal-Ribas; F. Sala; R. Sarrias; J. G 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 397 KB 👁 1 views

Beta-thromboglobulin and platelet-factor

Beta-thromboglobulin and platelet-factor 4 in patients with cancer: Correlation with the stage of disease and the effect of chemotherapy

✍ Hamid Al-Mondhiry 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB 👁 1 views

The percentage of aneuploid cells is sig

The percentage of aneuploid cells is significantly correlated with survival in accurately staged patients with stage 1 resected squamous cell lung cancer and long-term follow up

✍ Peter C. Van Bodegom; Prof Jan P. A. Baak; Conny Stroet-Van Galen; Nel W. Schipp 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 461 KB 👁 2 views

Serum CA 125 is of clinical value in the

Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma : Correlation with tumor parameters and disease activity

✍ Ikram A. Burney; Tariq Siddiqui; Imran Siddiqui 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 2 views

W e read with interest the article published in Cancer earlier this year regarding the elevation of CA 125 in patients with non-Hodgkin's lymphoma and its normalization with clinical response. 1 Earlier a case report had also emerged about elevation of CA 125 in a patient within tuberculous peritoni

Serum CA 125 is of clinical value in the

Serum CA 125 is of clinical value in the staging and follow-up of patients with non-hodgkin's lymphoma : Correlation with tumor parameters and disease activity

✍ Mario Lazzarino; Ester Orlandi; Catherine Klersy; Cesare Astori; Ercole Brusamol 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 2 views

## Background: Ca 125 is a glycoprotein produced by epithelial ovarian tumors and by mesothelial cells; its levels also have been shown to be elevated in patients with non-hodgkin's lymphoma (nhl). ## Methods: The authors evaluated serum ca 125 levels in patients with nhl to elucidate the frequen

Irradiation of the tumor bed alone after

Irradiation of the tumor bed alone after lumpectomy in selected patients with early-stage breast cancer treated with breast conserving therapy

✍ Vicini, Frank; Kini, Vijay R.; Chen, Peter; Horwitz, Eric; Gustafson, Gary; Beni 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## Backgrounds and Objectives: We present the interim findings of our in-house protocol treating the tumor bed alone after lumpectomy with low-dose-rate (LDR) interstitial brachytherapy in selected patients with early-stage breast cancer treated with breast conserving therapy (BCT). Methods: From